Waleed H. Hassanein, M.D., is a distinguished figure in the medical and healthcare industry, currently serving as the President and Chief Executive Officer at TransMedics Group Inc. Dr. Hassanein's journey in the medical field began with his education and training, where he earned his medical degree and honed his skills in thoracic and cardiovascular surgery. His early career was marked by significant contributions to the field of organ transplantation, where he developed a keen interest in improving the process and outcomes of organ transplants. At TransMedics Group Inc., Dr. Hassanein has been instrumental in steering the company towards its mission of transforming organ transplant therapy. Under his leadership, TransMedics has developed and commercialized the Organ Care System (OCS), a groundbreaking technology that maintains organs in a near-physiologic state during transport, significantly improving the viability and success rate of organ transplants. His strategic vision and dedication to innovation have positioned TransMedics as a leader in the organ transplant industry, earning the company recognition and accolades for its life-saving technology. Dr. Hassanein's achievements extend beyond his role at TransMedics. He is a respected member of the medical community, often speaking at conferences and contributing to academic journals on topics related to organ transplantation and healthcare innovation. His commitment to advancing medical science and improving patient outcomes has made him a pivotal figure in the field, and his leadership at TransMedics continues to drive the company forward in its mission to save and enhance lives through organ transplantation.